Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              XEN1101, a Novel Potassium Channel Modulator: Interim Data From an Ongoing, Long-Term, Open-Label Extension of a Phase 2b study (X-TOLE) in Adults with Focal Epilepsy

              Author:French, Jacqueline   Porter, Roger   Perucca, Emilio   Brodie, Martin   Rogawski, Michael   Harden, Cynthia   Qian, Jenny   Luzon-Rosenblut, Constanza   Kenney, Christopher   Beatch, Gregory   

              Session Name:S44: Epilepsy/Clinical Neurophysiology (EEG): Epilepsy Outcomes  

              Topic:Epilepsy/Clinical Neurophysiology (EEG)  

              Program Number:S44.008  

              Author Institution:New York University Grossman School of Medicine and NYU Langone Health, New York, NY, USA, New York, NY  University of Pennsylvania, Philadelphia, PA, USA, Philadelphia, PA  Monash University, Melbourne, Victoria, Australia and Austin Health, University of Melbourne, Heidelberg, Victoria, Australia, Heidelberg, Australia  University of Glasgow, Glasgow, UK, Glasgow, United Kingdom  University of California - Davis, Sacramento, CA, USA, Sacramento, CA  Xenon Pharmaceuticals Inc., Burnaby BC, Canada, Burnaby, BC, Canada  Xenon Pharmaceuticals Inc., Burnaby BC, Canada, Burnaby , BC, Canada